Promedior Raises $12 Million
Promedior Inc., a Malvern, Penn.-based developer of therapeutics for inflammatory and fibrotic diseases, has raised $12 million in Series C funding. Forbion Capital Partners led the round, and was joined by return backers Morgenthaler Ventures, HealthCare Ventures, Polaris Venture Partners and Easton Capital. The company has now raised $27 million in total VC funding.
16 March 2010•4 mins read
